![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Schrijver Iris Galli Stephen J
Publisher: Future Medicine
ISSN: 1741-0541
Source: Personalized Medicine, Vol.9, Iss.3, 2012-05, pp. : 243-246
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Use of pharmacogenetics in clinical medicine: hype or hope?
Personalized Medicine, Vol. 2, Iss. 4, 2005-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Whole‐Genome Sequencing in Personalized Therapeutics
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 6, 2012-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Premature guidance about whole-genome sequencing
By Ross Lainie Friedman Rothstein Mark A Clayton Ellen Wright
Personalized Medicine, Vol. 10, Iss. 6, 2013-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Deriving clinical action from whole-genome analysis
By Wall Dennis P Tonellato Peter J
Personalized Medicine, Vol. 9, Iss. 3, 2012-05 ,pp. :